14
Participants
Start Date
January 1, 2021
Primary Completion Date
January 11, 2023
Study Completion Date
January 11, 2023
Oral Methamphetamine
An initial 10 mg of oral methamphetamine (over-encapsulated to look similar to placebo capsule) study drug will be administered to assess tolerability, followed by a subsequent 15 mg oral dose (over-encapsulated to look similar to placebo capsule) two hours later.
Placebo oral capsule
One placebo capsule will be administered orally on treatment day, followed by a second oral placebo capsule two hours later.
San Francisco General Hospital, San Francisco
National Institute on Drug Abuse (NIDA)
NIH
University of California, San Francisco
OTHER